Annual report pursuant to Section 13 and 15(d)

Income Taxes (Tables)

v3.24.1
Income Taxes (Tables)
12 Months Ended
Dec. 31, 2023
Income Tax Disclosure [Abstract]  
Schedule of Components of Income Tax Expense (Benefit)
The components of the provision (benefit) for income taxes, in the consolidated statements of operations are as follows (in thousands):
For the years ended
December 31, 2023 December 31, 2022
Continuing Operations    
Current    
Federal $ 772  $ 1,040 
State 284  3,543 
$ 1,056  $ 4,583 
Deferred    
Federal (5,459) 72 
State (1,615) (210)
$ (7,074) $ (138)
Income taxes from continuing operations $ (6,018) $ 4,445 
Schedule of Effective Income Tax Rate Reconciliation
A reconciliation of the statutory federal income tax expense (benefit) to the effective tax is as follows (in thousands):
  2023 2022
Statutory Rate - federal $ (4,788) $ 4,811 
State taxes, net of federal benefit (1,133) 2,789 
Research & development tax credit (350) (1,200)
Permanent differences and other 510  (601)
Income taxes from continuing operations before valuation allowance (5,761) 5,799 
Change in valuation allowance (257) (1,354)
Income tax expense (benefit) $ (6,018) $ 4,445 
Total $ (6,018) $ 4,445 
Schedule of Deferred Tax Assets and Liabilities
The tax effects of the primary “temporary differences” between values recorded for assets and liabilities for financial reporting purposes and values utilized for measurement in accordance with tax laws giving rise to our deferred tax assets are as follows (in thousands):
  For the years ended
  December 31, 2023 December 31, 2022
Net operating loss and capital loss carryforward $ 4,649  $ 1,324 
Right of use asset (1,464) (1,466)
Other 4,972  2,684 
Capital lease obligations 1,464  1,466 
Depreciation (479) (705)
Amortization (1,612) (2,703)
Tax credit 350  — 
Valuation allowance (567) (824)
Total 7,313  (224)